Moreover, an epigenetic screening of 47 NSCLC patient samples revealed KEAP1 methylation in 47% of cases by quantitative methylation-specific PCR (qMSP) to detect a distinct group of CpG sites [84]. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.